Omega-3 fatty acids are one of the most-studied supplement classes in human history, with mixed enough results that you can find an authoritative-sounding scientist to defend nearly any position on them. The honest summary, after the large 2019 trials, is more specific than either “everyone should take fish oil” or “fish oil is useless.”
What omega-3s are
The two omega-3 fatty acids that matter clinically are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Both come primarily from marine sources — fatty fish, krill, algae. Plant omega-3s such as ALA from flax and walnut convert to EPA at a single-digit percentage and to DHA at a fraction of a percent. If you do not eat fish, plant sources will not deliver clinically relevant EPA or DHA.
DHA is structurally critical to neural and retinal membranes; EPA appears to dominate the anti-inflammatory effects via resolvins and other specialized pro-resolving mediators.
Cardiovascular: it depends on the dose and the population
Two large trials in 2019 mostly clarified the cardiovascular picture.
VITAL randomized 25,871 adults to 1 g per day of a combined EPA/DHA omega-3 (840 mg of active n-3) or placebo for primary prevention. The primary cardiovascular endpoint was not reduced. There was a signal for fewer myocardial infarctions in subgroup analysis, particularly in people who ate little fish at baseline, but the headline result was negative.1
REDUCE-IT randomized 8,179 statin-treated adults with elevated triglycerides to 4 g per day of icosapent ethyl (a purified EPA ethyl ester) or mineral oil placebo. The active arm had a 25 percent relative risk reduction in the composite cardiovascular endpoint over 4.9 years.2 The placebo choice was criticized — mineral oil may not be neutral — but the magnitude of the effect remains the largest in the field.
A 2019 meta-analysis of 13 trials involving 127,477 participants found small reductions in cardiovascular mortality and myocardial infarction with marine omega-3 supplementation, with the effect dose-dependent.3
The synthesis: a standard 1 g daily fish oil capsule does little for cardiovascular risk in well-fed adults eating a Western diet. A high-dose, purified EPA preparation reduces events in adults with elevated triglycerides on a statin. The middle ground — 2 to 3 g of combined EPA/DHA in adults who do not eat fish — is plausible but less directly tested.
Depression: small but real
A 2016 meta-analysis of 13 trials in major depressive disorder found that supplements high in EPA (more than 60 percent of total EPA+DHA, at doses of about 1 g of EPA per day) reduced depressive symptoms compared with placebo. EPA-low or DHA-dominant supplements did not.4 The effect size was modest but consistent enough to be a reasonable adjunct in mild-to-moderate depression in someone already engaged with appropriate clinical care.
Triglycerides: cleanly demonstrated
Omega-3s at 2 to 4 g per day lower triglycerides by roughly 20 to 30 percent in a dose-dependent way. This is the cleanest, most reproducible finding in the field and underlies the FDA approvals for both omega-3 acid ethyl esters and icosapent ethyl.
Practical guidance
A defensible position for most adults:
- Eat fatty fish (salmon, sardines, mackerel) twice a week if you tolerate it. This delivers EPA and DHA in a food matrix and is what the large epidemiological signal is built on.
- If you do not eat fish, 1 to 2 g of combined EPA+DHA daily from a tested fish oil or algae oil is reasonable, with no expectation of a dramatic cardiovascular effect.
- High-dose purified EPA (icosapent ethyl) is a prescription product appropriate for a specific clinical population — high triglycerides on a statin — not a general supplement.
- Check the label for actual EPA and DHA content, not total fish oil. Many 1000 mg “fish oil” capsules contain only 300 mg of EPA+DHA.
- Choose a brand that publishes third-party oxidation testing. Rancid fish oil is a real problem and may negate the benefit.
What it is not
Omega-3 supplementation is not a substitute for a diet pattern. The Mediterranean and Nordic patterns that show the strongest health outcomes contain fatty fish as one of many components. Taking a capsule does not import the rest of the pattern. And it does not consistently improve cognition in healthy adults, despite years of marketing claims.